| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |